Skip to main content

Advertisement

Table 2 Monitoring of laboratory parameters in 17 patients with leprosy enrolled in the safety study

From: Evaluation of safety tool for ambulatory leprosy patients at risk of adverse outcome

Laboratory parameter Pre-Implementation of safety tool Post-Implementation of safety tool
Number % Number %
Dapsone-induced hemolysis > 10 g/L 1/3 33.3 5/9 56.0
Elevated methemoglobin level 1/2 50.0 8/9 89.0
Glycemic monitoring after prednisone initiation 1/1 100.0 9/9 100.0
Steroid-induced hyperglycemia 0 0 4/9 44.4
Hepatic transaminase monitoring in those on Rifampin 6/8 75.0 9/9 100.0
Elevation of hepatic transaminases in those on Rifampin 0 0 2/9 22.2